Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Dec 1;102(11):1920–1926. doi: 10.1172/JCI4221

A critical role for transforming growth factor-beta in donor transfusion-induced allograft tolerance.

R Josien 1, P Douillard 1, C Guillot 1, M Müschen 1, I Anegon 1, J Chetritt 1, S Menoret 1, C Vignes 1, J P Soulillou 1, M C Cuturi 1
PMCID: PMC509143  PMID: 9835616

Abstract

Donor-specific (DST) or nonspecific blood transfusions administered before transplantation can enhance survival of vascularized allografts both in humans and animals but the immunological mechanisms of this effect remain unclear. We have analyzed the expression and the role of endogenous TGF-beta1 in a model of heart allograft tolerance, induced by pregraft DST in adult rats. We reported previously that this tolerance occurs despite a strong infiltration of leukocytes into the graft that are unable to produce both Th1- and Th2-related cytokines in vivo. Allografts from DST-treated rats express high levels of TGF-beta1 mRNA and active protein. This phenomenon is correlated with the rapid infiltration of leukocytes producing high amounts of TGF-beta1. TGF-beta1-producing cells are virtually absent among early infiltrating cells in rejected grafts but are found at a later time point. The induction of allograft tolerance in vivo is abrogated by administration of neutralizing anti-TGF-beta mAb. Moreover, overexpression of active TGF- beta1 in heart allografts using a recombinant adenovirus leads to prolonged graft survival in unmodified recipients. Taken together, our results identify TGF-beta as a critical cytokine involved in the suppression of allograft rejection induced by DST and suggest that TGF-beta-producing regulatory cells are also involved in allograft tolerance.

Full Text

The Full Text of this article is available as a PDF (303.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahuja S. S., Paliogianni F., Yamada H., Balow J. E., Boumpas D. T. Effect of transforming growth factor-beta on early and late activation events in human T cells. J Immunol. 1993 Apr 15;150(8 Pt 1):3109–3118. [PubMed] [Google Scholar]
  2. Armstrong H. E., Bolton E. M., McMillan I., Spencer S. C., Bradley J. A. Prolonged survival of actively enhanced rat renal allografts despite accelerated cellular infiltration and rapid induction of both class I and class II MHC antigens. J Exp Med. 1987 Mar 1;165(3):891–907. doi: 10.1084/jem.165.3.891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brabletz T., Pfeuffer I., Schorr E., Siebelt F., Wirth T., Serfling E. Transforming growth factor beta and cyclosporin A inhibit the inducible activity of the interleukin-2 gene in T cells through a noncanonical octamer-binding site. Mol Cell Biol. 1993 Feb;13(2):1155–1162. doi: 10.1128/mcb.13.2.1155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brunner A. M., Marquardt H., Malacko A. R., Lioubin M. N., Purchio A. F. Site-directed mutagenesis of cysteine residues in the pro region of the transforming growth factor beta 1 precursor. Expression and characterization of mutant proteins. J Biol Chem. 1989 Aug 15;264(23):13660–13664. [PubMed] [Google Scholar]
  5. Bugeon L., Cuturi M. C., Hallet M. M., Paineau J., Chabannes D., Soulillou J. P. Peripheral tolerance of an allograft in adult rats--characterization by low interleukin-2 and interferon-gamma mRNA levels and by strong accumulation of major histocompatibility complex transcripts in the graft. Transplantation. 1992 Aug;54(2):219–225. doi: 10.1097/00007890-199208000-00006. [DOI] [PubMed] [Google Scholar]
  6. Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979 Nov 27;18(24):5294–5299. doi: 10.1021/bi00591a005. [DOI] [PubMed] [Google Scholar]
  7. Cuturi M. C., Josien R., Douillard P., Pannetier C., Cantarovich D., Smit H., Ménoret S., Pouletty P., Clayberger C., Soulillou J. P. Prolongation of allogeneic heart graft survival in rats by administration of a peptide (a.a. 75-84) from the alpha 1 helix of the first domain of HLA-B7 01. Transplantation. 1995 Mar 15;59(5):661–669. doi: 10.1097/00007890-199503150-00003. [DOI] [PubMed] [Google Scholar]
  8. Dallman M. J., Shiho O., Page T. H., Wood K. J., Morris P. J. Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway. J Exp Med. 1991 Jan 1;173(1):79–87. doi: 10.1084/jem.173.1.79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dallman M. J., Wood K. J., Morris P. J. Specific cytotoxic T cells are found in the nonrejected kidneys of blood-transfused rats. J Exp Med. 1987 Feb 1;165(2):566–571. doi: 10.1084/jem.165.2.566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. David A., Chetritt J., Coupel-Clauce H., Tesson L., Cassard A., Blancho G., Charreau B., Sigalla J., Buzelin F., Le Mauff B. Adenovirus-mediated gene transfer in rat liver of interleukin 4 but not interleukin 10 produces severe acute hepatitis. Cytokine. 1997 Nov;9(11):818–829. doi: 10.1006/cyto.1997.0234. [DOI] [PubMed] [Google Scholar]
  11. Donahue J. K., Kikkawa K., Johns D. C., Marban E., Lawrence J. H. Ultrarapid, highly efficient viral gene transfer to the heart. Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4664–4668. doi: 10.1073/pnas.94.9.4664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Douillard P., Pannetier C., Josien R., Menoret S., Kourilsky P., Soulillou J. P., Cuturi M. C. Donor-specific blood transfusion-induced tolerance in adult rats with a dominant TCR-Vbeta rearrangement in heart allografts. J Immunol. 1996 Aug 1;157(3):1250–1260. [PubMed] [Google Scholar]
  13. Engelhardt J. F., Litzky L., Wilson J. M. Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a. Hum Gene Ther. 1994 Oct;5(10):1217–1229. doi: 10.1089/hum.1994.5.10-1217. [DOI] [PubMed] [Google Scholar]
  14. Flye M. W., Burton K., Mohanakumar T., Brennan D., Keller C., Goss J. A., Sicard G. A., Anderson C. B. Donor-specific transfusions have long-term beneficial effects for human renal allografts. Transplantation. 1995 Dec 27;60(12):1395–1401. doi: 10.1097/00007890-199560120-00004. [DOI] [PubMed] [Google Scholar]
  15. Josien R., Müschen M., Gilbert E., Douillard P., Heslan J. M., Soulillou J. P., Cuturi M. C. Fas ligand, tumor necrosis factor-alpha expression, and apoptosis during allograft rejection and tolerance. Transplantation. 1998 Oct 15;66(7):887–893. doi: 10.1097/00007890-199810150-00013. [DOI] [PubMed] [Google Scholar]
  16. Josien R., Pannetier C., Douillard P., Cantarovich D., Menoret S., Bugeon L., Kourilsky P., Soulillou J. P., Cuturi M. C. Graft-infiltrating T helper cells, CD45RC phenotype, and Th1/Th2-related cytokines in donor-specific transfusion-induced tolerance in adult rats. Transplantation. 1995 Nov 27;60(10):1131–1139. doi: 10.1097/00007890-199511270-00013. [DOI] [PubMed] [Google Scholar]
  17. Kehrl J. H., Roberts A. B., Wakefield L. M., Jakowlew S., Sporn M. B., Fauci A. S. Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes. J Immunol. 1986 Dec 15;137(12):3855–3860. [PubMed] [Google Scholar]
  18. Kehrl J. H., Taylor A. S., Delsing G. A., Roberts A. B., Sporn M. B., Fauci A. S. Further studies of the role of transforming growth factor-beta in human B cell function. J Immunol. 1989 Sep 15;143(6):1868–1874. [PubMed] [Google Scholar]
  19. Kehrl J. H., Wakefield L. M., Roberts A. B., Jakowlew S., Alvarez-Mon M., Derynck R., Sporn M. B., Fauci A. S. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med. 1986 May 1;163(5):1037–1050. doi: 10.1084/jem.163.5.1037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Krams S. M., Egawa H., Quinn M. B., Villanueva J. C., Garcia-Kennedy R., Martinez O. M. Apoptosis as a mechanism of cell death in liver allograft rejection. Transplantation. 1995 Feb 27;59(4):621–625. [PubMed] [Google Scholar]
  21. Lieubeau B., Garrigue L., Barbieux I., Meflah K., Gregoire M. The role of transforming growth factor beta 1 in the fibroblastic reaction associated with rat colorectal tumor development. Cancer Res. 1994 Dec 15;54(24):6526–6532. [PubMed] [Google Scholar]
  22. Lucas C., Bald L. N., Fendly B. M., Mora-Worms M., Figari I. S., Patzer E. J., Palladino M. A. The autocrine production of transforming growth factor-beta 1 during lymphocyte activation. A study with a monoclonal antibody-based ELISA. J Immunol. 1990 Sep 1;145(5):1415–1422. [PubMed] [Google Scholar]
  23. Massagué J. The transforming growth factor-beta family. Annu Rev Cell Biol. 1990;6:597–641. doi: 10.1146/annurev.cb.06.110190.003121. [DOI] [PubMed] [Google Scholar]
  24. Miller A., Lider O., Roberts A. B., Sporn M. B., Weiner H. L. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):421–425. doi: 10.1073/pnas.89.1.421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Mulé J. J., Schwarz S. L., Roberts A. B., Sporn M. B., Rosenberg S. A. Transforming growth factor-beta inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cells. Cancer Immunol Immunother. 1988;26(2):95–100. doi: 10.1007/BF00205600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ono K., Lindsey E. S. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg. 1969 Feb;57(2):225–229. [PubMed] [Google Scholar]
  27. Opelz G., Vanrenterghem Y., Kirste G., Gray D. W., Horsburgh T., Lachance J. G., Largiader F., Lange H., Vujaklija-Stipanovic K., Alvarez-Grande J. Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients. Transplantation. 1997 Apr 15;63(7):964–967. doi: 10.1097/00007890-199704150-00010. [DOI] [PubMed] [Google Scholar]
  28. Palladino M. A., Morris R. E., Starnes H. F., Levinson A. D. The transforming growth factor-betas. A new family of immunoregulatory molecules. Ann N Y Acad Sci. 1990;593:181–187. doi: 10.1111/j.1749-6632.1990.tb16110.x. [DOI] [PubMed] [Google Scholar]
  29. Pannetier C., Delassus S., Darche S., Saucier C., Kourilsky P. Quantitative titration of nucleic acids by enzymatic amplification reactions run to saturation. Nucleic Acids Res. 1993 Feb 11;21(3):577–583. doi: 10.1093/nar/21.3.577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Pawelec G. Suppressor cells in transplantation immunology: do recent advances in T cell immunobiology and cytokine networking contribute to the solution of an old conundrum? Transpl Immunol. 1993;1(3):172–181. doi: 10.1016/0966-3274(93)90044-9. [DOI] [PubMed] [Google Scholar]
  31. Powrie F., Carlino J., Leach M. W., Mauze S., Coffman R. L. A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells. J Exp Med. 1996 Jun 1;183(6):2669–2674. doi: 10.1084/jem.183.6.2669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Qin L., Chavin K. D., Ding Y., Favaro J. P., Woodward J. E., Lin J., Tahara H., Robbins P., Shaked A., Ho D. Y. Multiple vectors effectively achieve gene transfer in a murine cardiac transplantation model. Immunosuppression with TGF-beta 1 or vIL-10. Transplantation. 1995 Mar 27;59(6):809–816. [PubMed] [Google Scholar]
  33. Raju G. P., Belland S. E., Eisen H. J. Prolongation of cardiac allograft survival with transforming growth factor-beta 1 in rats. Transplantation. 1994 Aug 15;58(3):392–396. [PubMed] [Google Scholar]
  34. Ranges G. E., Figari I. S., Espevik T., Palladino M. A., Jr Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha. J Exp Med. 1987 Oct 1;166(4):991–998. doi: 10.1084/jem.166.4.991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Sato Y., Tsuboi R., Lyons R., Moses H., Rifkin D. B. Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system. J Cell Biol. 1990 Aug;111(2):757–763. doi: 10.1083/jcb.111.2.757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Shihab F. S., Tanner A. M., Shao Y., Weffer M. I. Expression of TGF-beta 1 and matrix proteins is elevated in rats with chronic rejection. Kidney Int. 1996 Dec;50(6):1904–1913. doi: 10.1038/ki.1996.512. [DOI] [PubMed] [Google Scholar]
  37. Shihab F. S., Yamamoto T., Nast C. C., Cohen A. H., Noble N. A., Gold L. I., Border W. A. Transforming growth factor-beta and matrix protein expression in acute and chronic rejection of human renal allografts. J Am Soc Nephrol. 1995 Aug;6(2):286–294. doi: 10.1681/ASN.V62286. [DOI] [PubMed] [Google Scholar]
  38. Soulillou J. P., Blandin F., Günther E., Lemoine V. Genetics of the blood transfusion effect on heart allografts in rats. Transplantation. 1984 Jul;38(1):63–67. doi: 10.1097/00007890-198407000-00015. [DOI] [PubMed] [Google Scholar]
  39. Stratford-Perricaudet L. D., Makeh I., Perricaudet M., Briand P. Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest. 1992 Aug;90(2):626–630. doi: 10.1172/JCI115902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Tsunawaki S., Sporn M., Ding A., Nathan C. Deactivation of macrophages by transforming growth factor-beta. Nature. 1988 Jul 21;334(6179):260–262. doi: 10.1038/334260a0. [DOI] [PubMed] [Google Scholar]
  41. Wahl S. M., McCartney-Francis N., Allen J. B., Dougherty E. B., Dougherty S. F. Macrophage production of TGF-beta and regulation by TGF-beta. Ann N Y Acad Sci. 1990;593:188–196. doi: 10.1111/j.1749-6632.1990.tb16111.x. [DOI] [PubMed] [Google Scholar]
  42. Wahl S. M., McCartney-Francis N., Mergenhagen S. E. Inflammatory and immunomodulatory roles of TGF-beta. Immunol Today. 1989 Aug;10(8):258–261. doi: 10.1016/0167-5699(89)90136-9. [DOI] [PubMed] [Google Scholar]
  43. Wahl S. M. Transforming growth factor beta: the good, the bad, and the ugly. J Exp Med. 1994 Nov 1;180(5):1587–1590. doi: 10.1084/jem.180.5.1587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Wallick S. C., Figari I. S., Morris R. E., Levinson A. D., Palladino M. A. Immunoregulatory role of transforming growth factor beta (TGF-beta) in development of killer cells: comparison of active and latent TGF-beta 1. J Exp Med. 1990 Dec 1;172(6):1777–1784. doi: 10.1084/jem.172.6.1777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Waltenberger J., Wanders A., Fellström B., Miyazono K., Heldin C. H., Funa K. Induction of transforming growth factor-beta during cardiac allograft rejection. J Immunol. 1993 Jul 15;151(2):1147–1157. [PubMed] [Google Scholar]
  46. Weiner H. L., Friedman A., Miller A., Khoury S. J., al-Sabbagh A., Santos L., Sayegh M., Nussenblatt R. B., Trentham D. E., Hafler D. A. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol. 1994;12:809–837. doi: 10.1146/annurev.iy.12.040194.004113. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES